These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 12858356)
21. Androgen receptor gene amplification and protein expression in recurrent prostate cancer. Ford OH; Gregory CW; Kim D; Smitherman AB; Mohler JL J Urol; 2003 Nov; 170(5):1817-21. PubMed ID: 14532783 [TBL] [Abstract][Full Text] [Related]
22. Identification and characterization of androgen receptor associated coregulators in prostate cancer cells. Sampson ER; Yeh SY; Chang HC; Tsai MY; Wang X; Ting HJ; Chang C J Biol Regul Homeost Agents; 2001; 15(2):123-9. PubMed ID: 11501969 [TBL] [Abstract][Full Text] [Related]
23. Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles. Tamura K; Furihata M; Tsunoda T; Ashida S; Takata R; Obara W; Yoshioka H; Daigo Y; Nasu Y; Kumon H; Konaka H; Namiki M; Tozawa K; Kohri K; Tanji N; Yokoyama M; Shimazui T; Akaza H; Mizutani Y; Miki T; Fujioka T; Shuin T; Nakamura Y; Nakagawa H Cancer Res; 2007 Jun; 67(11):5117-25. PubMed ID: 17545589 [TBL] [Abstract][Full Text] [Related]
24. Pharmacological targeting of constitutively active truncated androgen receptor by nigericin and suppression of hormone-refractory prostate cancer cell growth. Mashima T; Okabe S; Seimiya H Mol Pharmacol; 2010 Nov; 78(5):846-54. PubMed ID: 20709811 [TBL] [Abstract][Full Text] [Related]
25. The relationship between proangiogenic gene expression levels in prostate cancer and their prognostic value for clinical outcomes. Mori R; Dorff TB; Xiong S; Tarabolous CJ; Ye W; Groshen S; Danenberg KD; Danenberg PV; Pinski JK Prostate; 2010 Nov; 70(15):1692-700. PubMed ID: 20564320 [TBL] [Abstract][Full Text] [Related]
26. Renin-angiotensin system is an important factor in hormone refractory prostate cancer. Uemura H; Hasumi H; Ishiguro H; Teranishi J; Miyoshi Y; Kubota Y Prostate; 2006 Jun; 66(8):822-30. PubMed ID: 16482568 [TBL] [Abstract][Full Text] [Related]
27. Co-assessment of cytoplasmic and nuclear androgen receptor location in prostate specimens: potential implications for prostate cancer development and prognosis. Diallo JS; Aldejmah A; Mouhim AF; Fahmy MA; Koumakpayi IH; Sircar K; Bégin LR; Mes-Masson AM; Saad F BJU Int; 2008 May; 101(10):1302-9. PubMed ID: 18294307 [TBL] [Abstract][Full Text] [Related]
28. Hic-5/ARA55, a LIM domain-containing nuclear receptor coactivator expressed in prostate stromal cells. Heitzer MD; DeFranco DB Cancer Res; 2006 Jul; 66(14):7326-33. PubMed ID: 16849583 [TBL] [Abstract][Full Text] [Related]
29. Change of the cell cycle after flutamide treatment in prostate cancer cells and its molecular mechanism. Wang Y; Shao C; Shi CH; Zhang L; Yue HH; Wang PF; Yang B; Zhang YT; Liu F; Qin WJ; Wang H; Shao GX Asian J Androl; 2005 Dec; 7(4):375-80. PubMed ID: 16281084 [TBL] [Abstract][Full Text] [Related]
30. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer. Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446 [TBL] [Abstract][Full Text] [Related]
31. Low stroma androgen receptor level in normal and tumor prostate tissue is related to poor outcome in prostate cancer patients. Wikström P; Marusic J; Stattin P; Bergh A Prostate; 2009 Jun; 69(8):799-809. PubMed ID: 19189305 [TBL] [Abstract][Full Text] [Related]
32. Androgen receptor status in female breast cancer: RT-PCR and Western blot studies. Bryś M; Wójcik M; Romanowicz-Makowska H; Krajewska WM J Cancer Res Clin Oncol; 2002 Feb; 128(2):85-90. PubMed ID: 11862478 [TBL] [Abstract][Full Text] [Related]
33. Amplification of the androgen receptor gene in bone metastases from hormone-refractory prostate cancer. Brown RS; Edwards J; Dogan A; Payne H; Harland SJ; Bartlett JM; Masters JR J Pathol; 2002 Oct; 198(2):237-44. PubMed ID: 12237884 [TBL] [Abstract][Full Text] [Related]
34. Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer. Henshall SM; Quinn DI; Lee CS; Head DR; Golovsky D; Brenner PC; Delprado W; Stricker PD; Grygiel JJ; Sutherland RL Cancer Res; 2001 Jan; 61(2):423-7. PubMed ID: 11212224 [TBL] [Abstract][Full Text] [Related]
35. Differently regulated androgen receptor transcriptional complex in prostate cancer compared with normal prostate. Kinoshita M; Nakagawa T; Shimizu A; Katsuoka Y Int J Urol; 2005 Apr; 12(4):390-7. PubMed ID: 15948728 [TBL] [Abstract][Full Text] [Related]
37. DNA methylation in the androgen receptor gene promoter region in rat prostate cancers. Takahashi S; Inaguma S; Sakakibara M; Cho YM; Suzuki S; Ikeda Y; Cui L; Shirai T Prostate; 2002 Jun; 52(1):82-8. PubMed ID: 11992622 [TBL] [Abstract][Full Text] [Related]
38. Prognostic value of the androgen receptor and its coactivators in patients with D1 prostate cancer. Mori R; Wang Q; Quek ML; Tarabolous C; Cheung E; Ye W; Groshen S; Hawes D; Togo S; Shimada H; Danenberg KD; Danenberg PV; Pinski JK Anticancer Res; 2008; 28(1B):425-30. PubMed ID: 18383880 [TBL] [Abstract][Full Text] [Related]
39. Combined analysis of multiple mRNA markers by RT-PCR assay for prostate cancer diagnosis. Neves AF; Araújo TG; Biase WK; Meola J; Alcântara TM; Freitas DG; Goulart LR Clin Biochem; 2008 Oct; 41(14-15):1191-8. PubMed ID: 18640109 [TBL] [Abstract][Full Text] [Related]
40. Expression of androgen receptor co-regulators in the testes of men with azoospermia. Lan KC; Hseh CY; Lu SY; Chang SY; Shyr CR; Chen YT; Kang HY; Huang KE Fertil Steril; 2008 May; 89(5 Suppl):1397-405. PubMed ID: 17919607 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]